ReviewFrontiers in immunology2025

Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature.

Xiaofang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.